P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY

por Trab, T., Baech, J., Hjort Jakobsen, L., Husby, S., Tang Severinsen, M., Eloranta, S., Gørløv, J. S., Jørgensen, J. M., Gudbrandsdottir, S., Stauffer Larsen, T., Brown, P., Smedby, K. E., Christoffer El-Galaly, T.
Publicado 2022

P1093: A NEW PROGNOSTIC MODEL FOR INDIVIDUAL OUTCOME PREDICTION IN ADVANCED-STAGE HODGKIN LYMPHOMA.

por Rask Kragh Jørgensen, R., Eloranta, S., Tang Severinsen, M., Kiesbye Øvlisen, A., Bjøro Smeland, K., Kiserud, C., Haaber Christensen, J., Hutchings, M., Bo-Dahl Sørensen, R., Kamper, P., Glimelius, I., Smedby, K. E., Bergström, F., El-Galaly, T. C., Hjort Jakobsen, L.
Publicado 2022